My Views
Events
Calendars
Account
Settings
Sign Out
Sign In:
Benefits of Signing In
Sign In:
PENNMED SSO
Google
Microsoft
Facebook
Benefits of Signing In
Registration
(GMT-12:00) International Date Line West
(GMT-11:00) Midway Island, Samoa
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana, Baja California
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua, La Paz, Mazatlan - New
(GMT-07:00) Chihuahua, La Paz, Mazatlan - Old
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara, Mexico City, Monterrey…
(GMT-06:00) Guadalajara, Mexico City, Monterrey…
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota, Lima, Quito, Rio Branco
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas, La Paz
(GMT-04:00) Manaus
(GMT-04:00) Paraguay
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires, Georgetown
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT) Casablanca, Monrovia, Reykjavik
(GMT) Greenwich Mean Time : Dublin, Edinburgh,…
(GMT+01:00) Amsterdam, Berlin, Bern, Rome,…
(GMT+01:00) Belgrade, Bratislava, Budapest,…
(GMT+01:00) Brussels, Copenhagen, Madrid, Paris
(GMT+01:00) Sarajevo, Skopje, Warsaw, Zagreb
(GMT+01:00) West Central Africa
(GMT+02:00) Amman
(GMT+02:00) Athens, Beirut, Istanbul, Minsk
(GMT+02:00) Beirut
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare, Pretoria
(GMT+02:00) Helsinki, Kyiv, Riga, Sofia,…
(GMT+02:00) Jerusalem
(GMT+02:00) Windhoek
(GMT+03:00) Baghdad
(GMT+03:00) Kuwait, Riyadh
(GMT+03:00) Moscow, St. Petersburg, Volgograd
(GMT+03:00) Nairobi
(GMT+03:00) Tbilisi
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi, Muscat
(GMT+04:00) Baku
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad, Karachi, Tashkent
(GMT+05:30) Chennai, Kolkata, Mumbai, New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty, Novosibirsk
(GMT+06:00) Astana, Dhaka
(GMT+06:30) Yangon (Rangoon)
(GMT+07:00) Bangkok, Hanoi, Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+08:00) Beijing, Chongqing, Hong Kong, Urumqi
(GMT+08:00) Irkutsk, Ulaan Bataar
(GMT+08:00) Kuala Lumpur, Singapore
(GMT+08:00) Perth
(GMT+08:00) Taipei
(GMT+09:00) Osaka, Sapporo, Tokyo
(GMT+09:00) Seoul
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra, Melbourne, Sydney
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Hobart
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan, Solomon Is., New Caledonia
(GMT+12:00) Auckland, Wellington
(GMT+12:00) Fiji, Kamchatka, Marshall Is.
(GMT+13:00) Nuku'alofa
Time Zone
Neuro-Oncology Brain Tumor Symposium 2020 - Virtual Conference
When
Friday, October 30, 2020, 7am – 3:15pm EDT
Location
VIRTUAL PROGRAM
Type of Event
Conference
Sponsor
Abramson Cancer Center
Learning Objectives
Upon completion of this course, participants should be able to:
* Implement WHO classification of brain tumors and how molecular profiling affects diagnosis, MRI interpretation, prognosis and therapy of patients with gliomas
* List advances in the surgical treatment of brain tumors including the use of fiber tracking (DTI), awake craniotomy, brain mapping, laser thermocoagulation, and fluorescence IGS (image- guided surgery)
*Identify the role of immune system to defend against CNS malignancy including the new class of checkpoint inhibitors and the potential use of CAR-T cell therapy
• List the benefits and application of proton therapy for low-grade and malignant gliomas
*Identify the scientific rationale, practical application, and survival benefit of electric field therapy for malignant brain tumors
• Identify the rationale and potential for viral therapies for malignant gliomas
*List recent advances in anti-angiogenic therapy in the treatment of gliomas
At the completion of this course patients and families should be able to:
* Identify the latest advances in brain cancer treatment
* Demonstrate familiarity with the terminology and technical aspects of brain cancer care
* Demonstrate patient-active behavior in working with the healthcare team to make ongoing treatment decisions
Accreditation
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation of Credit
PHYSICIANS
: Penn Medicine designates this live activity for a maximum of
6.5
AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES
: The program will award
6.5
contact hours.
PHYSICIAN ASSISTANTS
: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of
6.5
Category 1 credits for completing this activity.
Disclosures
Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.
Sorry. The sign-up deadline for this event has passed
The following error(s) occurred during execution of this command:
Close
Privacy Policy
Terms of Use
Please fix errors above to continue
Privacy Policy
Terms of Use